OSRH Q2 2025 Earnings — OSR Holdings, Inc. Revenue & Financial Results | Market Cap Arena

OSRHOSR Holdings, Inc.

$13M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$32,7822.9% margin

Operating Income

-$5M-460.5% margin

Net Income

-$5M-460.2% margin

EPS (Diluted)

$-1.17

QoQ Revenue Growth

+49.2%

Cash Flow

Operating Cash Flow

-$43,773

Free Cash Flow

-$43,769

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$185M

Total Liabilities

$46M

Stockholders' Equity

$139M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$32,782	$0	—
Operating Income	-$5M	-$476,000	-998.6%
Net Income	-$5M	-$97,295	-5270.5%